Search
for
Sort by
Research 61–90 of 1000+
- Hepatitis C‐related mixed type vitiligo in a patient with Ivemark syndrome
- Case Report: Bimekizumab for dissecting cellulitis of the scalp
- Severe Psoriasis Leading to Scarring Alopecia of the Scalp Responding to Biologic Therapy
- Network pharmacology and in vivo experimental analysis for validating the antifibrotic potential of Punica granatum leaves against skin scleroderma: the role of oxidative stress, inflammation and TGF-β1/Snail 1/p-Smad 3 signaling pathway
- Sycosis Barbae Treated With Bimekizumab
- Detection of Serum Levels of Interleukins-17, 21, 6 and Tumor Necrosis Factor-α in Patients with Patchy Alopecia Areata and Their Association with Disease Severity
- 508 Hair follicle rejuvenation is induced by topical minoxidil administration in a humanized mouse model of androgenetic alopecia
- 128 Bimekizumab led to rapid & deep normalisation of molecular signatures associated with PASI sub-components, preceding clinical skin clearance
- 496 Understanding the mechanism of action of secukinumab using lesional hidradenitis suppurativa skin organ culture
- 52814 Minoxidil exerts skin rejuvenation effects in human androgenetic alopecia xenotransplants in vivo
- 371 Hair follicles are critical modulators of skin barrier function
- Ophiasis Alopecia Areata in a Patient With Spondyloarthritis on Secukinumab: A Case Report and Review of the Literature
- 1326 Translation-dependent skin hyperplasia is promoted by type 1/17 inflammation in psoriasis
- Serum Interleukin 17 as a Marker for Alopecia Areata Severity: A Case-Control Study
- 581 Spontaneous, Intrinsic Aging in Organ-Cultured Human Skin as Novel Ex Vivo Assay to Test Candidate Anti-Aging Actives
- 269 Down-regulatory role of cholecystokinin on psoriatic epidermal inflammation
- Clinical Snippets
- Differential diagnosis of trichotillomania by trichoscopy
- Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
- Inflammatory and Anti-Inflammatory Parameters in PCOS Patients Depending on Body Mass Index: A Case-Control Study
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Ixekizumab improves physical function, quality of life, and work productivity in biologic disease-modifying antirheumatic drug-naive patients with active psoriatic arthritis
- LB1007 Systemic treatment with a KLK5 inhibitor shows efficacy in a murine model of Netherton syndrome
- LB1667 Successful treatment of rare linear lichen planopilaris with ixekizumab
- Successful treatment of rare linear lichen planopilaris with Ixekizumab
- IL-17 axis is a significant driver of skin inflammation in Card14 mutant pityriasis rubra pilaris model mice
- Estranys matins de febrer: Pauline Fondevila
- IL-17-producing γδ T cells enhance bone regeneration
- A Novel Role of IL-17+ Cell Subsets in Ross River Virus-Induced Arthritic Disease
- Dermatological Manifestations of COVID-19: A Brief Review